Rightway: its Form D reports $22.7 million of its $155 million Series E under payments to executive officers, directors or promoters; the filing gives no explanation

What the record shows

As of 2026-10-05. Item 16 of a Form D reports money paid, or to be paid, to the company's own executive officers, directors or promoters. It is a disclosed use of proceeds, not a finding of wrongdoing.

Rightway's Form D is one of the offerings counted in Q3 2026 in Paid to insiders: the quarterly count.

1. On 24 September 2026 Rightway announced "that it has raised $155 million in Series E financing led by Francisco Partners", with Thrive Capital and Khosla Ventures taking part, and said it "will use the Series E financing to expand its AI capabilities and the technology that powers its pharmacy benefits model."Source: prnewswire.com
2. The Form D that Rightway Healthcare, Inc. filed with the SEC on 8 September 2026 reports $154,999,891 sold. The form asks how much of the gross proceeds "has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters". Rightway's answer is $22,671,053. The figure is not marked as an estimate, and the filing gives no explanation of the payments.Source: sec.gov
3. The announcement does not mention payments to officers or directors. One ordinary explanation would be the company or its investors buying shares from them as part of the round; the filing does not say.Source: prnewswire.com · sec.gov